icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
 
 
 
NGM282 DEMONSTRATES ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES THAT ARE INDEPENDENT OF STEATOSIS REDUCTION IN A FARNESOIDX RECEPTOR (FXR)-DEFICIENT, DIET-INDUCED ANIMAL MODEL OF NON-ALCOHOLIC STEATOHEPATITIS(NASH)
 
 
  Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
 
Lei Ling, Mei Zhou, Marc Learned, Stephen Rossi, Alex DePaoli, Hui Tian NGM Biopharmaceuticals, Inc., South San Francisco, CA 94080, USA

1214181

1214182

1214183

1214184

1214185

1214186

1214187

1214188